Effects of radiotherapy and estramustine on the microvasculature in malignant glioma

被引:0
作者
M Johansson
A T Bergenheim
A Widmark
R Henriksson
机构
[1] Umeå University,Departments of Oncology
[2] Umeå University,Departments of Neurosurgery
来源
British Journal of Cancer | 1999年 / 80卷
关键词
angiogenesis; chemotherapy; glioma; radiotherapy; VEGF;
D O I
暂无
中图分类号
学科分类号
摘要
Tumour angiogenesis is essential for progression of solid tumours and constitutes an interesting target for therapy. However, impaired tumour blood supply may also be an important obstacle for treatment by radiotherapy and chemotherapy. Estramustine has been shown to increase tumour blood flow and potentiate the effect of radiotherapy in experimental glioma. This study investigated the effects of fractionated radiotherapy and estramustine on angiogenesis in malignant glioma. The intracerebral BT4C rat glioma model was used and the animals were given whole brain radiotherapy 4 Gy × 5 days alone or in combination with estramustine 20 mg kg-1 i.p. daily. Tumour microvascular density (MVD) was assessed by manual and computerized morphometrical analysis. Expression of vascular endothelial growth factor (VEGF) was studied by in situ hybridization. Radiotherapy decreased MVD to 157 vessels per mm2 compared to 217 vessels per mm2 in controls. Estramustine counteracted this anti-angiogenic effect and potentiated the anti-tumoural effect of radiotherapy. In addition, vessel size increased after estramustine treatment. Five days after completion of radiotherapy the expression of VEGF was increased in the centre of the tumours. In conclusion, fractionated radiotherapy decreases microvascular density in experimental malignant glioma. This effect was abolished by estramustine. The anti-vascular effect of irradiation is important to recognize when combining radiotherapy with cytotoxic drugs.
引用
收藏
页码:142 / 148
页数:6
相关论文
共 146 条
  • [1] Baker DG(1989)The response of the microvascular system to radiation: a review Cancer Invest 7 287-294
  • [2] Krochak RJ(1997)Overexpression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis Carcinogenesis 18 1155-1161
  • [3] Banerjee SK(1993)Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans Br J Cancer 67 358-361
  • [4] Sarkar DK(1994)Cytotoxic effect and uptake of estramustine in a rat glioma model Int J Oncol 5 293-299
  • [5] Weston AP(1994)Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma Cancer Res 54 4974-4979
  • [6] De A(1995)Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo J Neuro-Oncol 23 191-200
  • [7] Campbell DR(1996)Estramustine in malignant glioma J Neuro Oncol 30 81-89
  • [8] Bergenheim AT(1993)Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth Endocrinology 133 829-837
  • [9] Gunnarsson PO(1991)The current status of targeting tumour vasculature as a means of cancer therapy: an overview Int J Radiat Biol 60 401-408
  • [10] Edman K(1982)Endothelial-cell proliferation in experimental tumours Br J Cancer 46 711-720